These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Optimizing glycemic control with insulin glargine. Williams JB Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834 [No Abstract] [Full Text] [Related]
28. Ten errors to avoid in managing type 2 diabetes. Getting back to the basics. Trachtenbarg DE Postgrad Med; 1998 Aug; 104(2):35-9, 43. PubMed ID: 9721577 [TBL] [Abstract][Full Text] [Related]
29. Comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508. Conget I; Aronson R; Lee S; Cohen O; Reznik Y Diabetes Care; 2014 Nov; 37(11):e245-6. PubMed ID: 25342842 [No Abstract] [Full Text] [Related]
30. Insulin degludec/liraglutide (Xultophy 100/3.6) for type 2 diabetes. Med Lett Drugs Ther; 2017 Sep; 59(1529):147-149. PubMed ID: 28880845 [No Abstract] [Full Text] [Related]
31. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus. Gudat U; Bungert S; Kemmer F; Heinemann L Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119 [TBL] [Abstract][Full Text] [Related]
33. Type II diabetes: insulin versus oral agents. Martin DB N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646 [No Abstract] [Full Text] [Related]
34. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment. McDonnell ME J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012 [TBL] [Abstract][Full Text] [Related]
36. Treatment of type 2 diabetes: one extreme to another. Zaidi S Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079 [No Abstract] [Full Text] [Related]
37. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus. Spellman CW J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Bressler R; Johnson DG Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543 [TBL] [Abstract][Full Text] [Related]
40. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine. Pouwels MJ; Den Heijer M; Blom HJ; Tack CJ; Hermus AR Diabetes Care; 2003 May; 26(5):1637-9. PubMed ID: 12716838 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]